Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Nitric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nitric Acid SCHEMBL16334632 | 1.00 | CA5A (0.89) | — | |
| Nitric Acid SCHEMBL11649686 | 1.00 | CA5A (0.89) | — | |
| Nitric Acid SCHEMBL509381 | 1.00 | — | — | |
| Nitric Acid SCHEMBL2226059 | 1.00 | — | — | |
| Nitric Acid SCHEMBL4217882 | 0.95 | CA5A (0.80) | — | |
| Nitric Acid SCHEMBL9101012 | 0.95 | — | — | |
| Nitric Acid SCHEMBL11441675 | 0.95 | — | — | |
| Nitric Acid SCHEMBL675616 | 0.95 | — | — | |
| Nitric Acid SCHEMBL1266084 | 0.95 | — | — | |
| Nitric Acid SCHEMBL6907552 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115623801-A | Laminated solar cell with tunneling junction structure and preparation method thereof | 浙江合特光电有限公司 | 2023-01-17 | — | — | CN | disclosed |
| CN-108014797-A | A kind of monatomic catalyst of supported silver for being used for unsaturated higher alcohols oxidation and preparation method thereof | 万华化学集团股份有限公司 | 2018-05-11 | — | — | CN | disclosed |
| US-9718013-B2 | Formation and immobilization of small particles by using polyelectrolyte multilayers | KX TECHNOLOGIES LLC (US) | 2017-08-01 | — | — | US | disclosed |
| CN-104159650-B | By using polyelectrolyte multilayer, the method for formation fixing particulate | KX技术有限公司 | 2017-02-22 | — | — | CN | disclosed |
| EP-2819760-A1 | FORMATION AND IMMOBILIZATION OF SMALL PARTICLES BY USING POLYELECTROLYTE MULTILAYERS | KX Technologies LLC (US) | 2015-01-07 | — | — | EP | disclosed |
| WO-2013130171-A1 | FORMATION AND IMMOBILIZATION OF SMALL PARTICLES BY USING POLYELECTROLYTE MULTILAYERS | KX TECHNOLOGIES, LLC (US) | 2013-09-06 | — | — | WO | disclosed |
| US-20130224378-A1 | FORMATION AND IMMOBILIZATION OF SMALL PARTICLES BY USING POLYELECTROLYTE MULTILAYERS | KX TECHNOLOGIES, LLC (US) | 2013-08-29 | — | — | US | disclosed |
| US-8158578-B2 | Methods for treating neurological deficits | NEUROREPAIR, INC. (US) | 2012-04-17 | — | — | US | disclosed |
| US-20110071078-A1 | METHODS FOR TREATING NEUROLOGICAL DEFICITS | REID JAMES STEVEN | 2011-03-24 | — | — | US | disclosed |
| US-7790669-B1 | Methods for treating neurological deficits by intrastriatal administration of transforming growth factor alpha (TGF-α) | NEUROREPAIR, INC. (US) | 2010-09-07 | — | — | US | disclosed |
| US-4925919-A | Purified interleukin 2 | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 1990-05-15 | — | — | US | disclosed |
| US-4908433-A | Increases proliferation of T-cells and normalizes immune response | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1990-03-13 | — | — | US | disclosed |
| US-4908434-A | Treating human lymphocytes to obtain medium containing interleukin-2, recovering protein components, subjecting protein components to anion exchange chromatography, gel filtration chromatography, hydrophobic chromatography | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1990-03-13 | — | — | US | disclosed |
| US-4778879-A | AIDS, CANCER-RELATED IMMUNODEFICIENCY DISORDERS | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1988-10-18 | — | — | US | disclosed |
| EP-0073247-B1 | SILVER STAINS FOR PROTEIN IN GELS | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce (US) | 1985-06-19 | — | — | EP | disclosed |
| US-4468466-A | Silver stains for protein in gels--a modified procedure | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1984-08-28 | — | — | US | disclosed |
| US-4405720-A | ULTRA-SENSITIVE, REDOX | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1983-09-20 | — | — | US | disclosed |
| EP-0073247-A4 | SILVER STAINS FOR PROTEIN IN GELS. | US HEALTH (US) | 1983-04-18 | — | — | EP | disclosed |
| EP-0073247-A1 | SILVER STAINS FOR PROTEIN IN GELS. | US COMMERCE (US) | 1983-03-09 | — | — | EP | disclosed |
| WO-1982003128-A1 | SILVER STAINS FOR PROTEIN IN GELS | US COMMERCE (US) | 1982-09-16 | — | — | WO | disclosed |